SMITH IAN F

CIK 00011970328 companiesBEDFORD, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001197032

Recent Transactions

50 trades

Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2026-02-17+129,000→ 129,000 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2026-02-17+193,000→ 193,000 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2026-01-06+4,573→ 131,264 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2026-01-06−4,573→ 0 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2026-01-02+13,761→ 13,761 total
Award
Solid Biosciences Inc.$SLDB
Stock Option (Right to Buy)
2026-01-02+18,012→ 18,012 total
Award
Stoke Therapeutics, Inc.$STOK
Stock Option (Right to Buy)
2025-10-08+570,000→ 570,000 total
Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2025-10-08+380,000→ 380,000 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2025-10-06+4,573→ 126,692 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-10-06−4,573→ 4,573 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-07-06−4,573→ 9,146 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2025-07-06+4,573→ 122,119 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2025-06-17$4.79/sh+25,000→ 25,000 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2025-06-12+77,500→ 77,500 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2025-04-06+4,574→ 117,546 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-04-06−4,574→ 13,719 total
Award
Stoke Therapeutics, Inc.$STOK
Stock Option (Right to Buy)
2025-03-20+238,420→ 238,420 total
Award
Solid Biosciences Inc.$SLDB
Stock Option (Right to Buy)
2025-01-06+22,148→ 22,148 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-01-06+18,293→ 18,293 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2025-01-03+3,255→ 112,972 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-01-03−3,255→ 0 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2024-10-03−3,255→ 3,255 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2024-10-03+3,255→ 109,717 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2024-07-03−3,255→ 6,510 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2024-07-03+3,255→ 106,462 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Options (Right to buy)
2024-06-26$5.52/sh+16,000→ 16,000 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2024-06-11+34,400→ 34,400 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2024-06-05+7,639→ 7,639 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2024-04-03−3,256→ 9,765 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2024-04-03+3,256→ 103,207 total
Award
Solid Biosciences Inc.$SLDB
Stock Option (Right to Buy)
2024-01-03+15,112→ 15,112 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2024-01-03+13,021→ 13,021 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2024-01-03−15,570→ 0 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2024-01-03+15,570→ 99,948 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2023-12-08+26,977→ 26,977 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2023-10-03+15,569→ 84,378 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2023-10-03−15,569→ 15,570 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2023-09-19+96,340→ 96,340 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2023-07-03−15,570→ 31,139 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2023-07-03+15,570→ 68,809 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2023-06-21+16,000→ 16,000 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2023-06-06+9,650→ 9,650 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2023-04-03−15,569→ 46,709 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2023-04-03+15,569→ 53,239 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2023-01-03−1,620→ 0 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Stock Option (Right to Buy)
2023-01-03+70,796→ 70,796 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2023-01-03+1,620→ 37,670 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2023-01-03+62,278→ 62,278 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2022-12-13+9,650→ 9,650 total
Award
Solid Biosciences Inc.$SLDB
Common Stock
2022-12-02+13,172→ 356,380 total

Companies

Recent Filings

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730

View on SEC.gov